![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 221/16 | |
C07D 401/12 | |||
C07D 405/12 | |||
A61K 31/444 | |||
A61K 31/435 | |||
A61P 3/10 |
(11) | Number of the document | 3055288 |
(13) | Kind of document | T |
(96) | European patent application number | 14852689.0 |
Date of filing the European patent application | 2014-09-30 | |
(97) | Date of publication of the European application | 2016-08-17 |
(45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2014/087857 |
Date | 2014-09-30 |
(87) | Number | WO 2015/051725 |
Date | 2015-04-16 |
(30) | Number | Date | Country code |
PCT/CN2013/0848 | 2013-10-08 | WO |
(72) |
BIFTU, Tesfaye, US
BIJU, Purakkatle, US
COLLETTI, Steven L., US
CUI, Mingxiang, CN
HAGMANN, William K., US
HU, Bin, CN
JOSIEN, Hubert, US
KAR, Nam Fung, US
NAIR, Anilkumar, US
NARGUND, Ravi, US
SPERBECK, Donald M., US
ZHU, Chen, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(54) | ANTIDIABETIC TRICYCLIC COMPOUNDS |
ANTIDIABETIC TRICYCLIC COMPOUNDS |